A METHOD FOR THE HIGH LEVEL EXPRESSION OF THE ACTIVE LYMPHOTOXIN-BETA RECEPTOR… Application EP-3006563-A1 European Patent Office 13 Apr 2016
Method for increasing expression of active tumor necrosis factor receptor family member-Ig… Grant US-8709759-B2 United States of America 29 Apr 2014
Compositions comprising variant LT-B-R-IG fusion proteins Grant US-8338376-B2 United States of America 25 Dec 2012
Method for the high level expression of active tumor necrosis receptor family member… Grant US-8283138-B2 United States of America 09 Oct 2012
A METHOD FOR THE HIGH LEVEL EXPRESSION OF THE ACTIVE FORM OF LYMPHOTOXIN-BETA RECEPTOR… Grant EP-1141248-B1 European Patent Office 07 Dec 2011
Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor Grant US-8067375-B2 United States of America 29 Nov 2011
A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin… Application EP-2374872-A3 European Patent Office 19 Oct 2011
Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions Grant US-7585946-B2 United States of America 08 Sep 2009
CULTURES OF E1-IMMORTALIZED CELLS AND PROCESSES FOR CULTURING THE SAME TO INCREASE… Application WO-2004099396-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2004